Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 10 October 2024
Adhoc Press Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Press Release, 8 August 2024
Adhoc Press Release
Kuros Biosciences Reports First Half of 2024 Results
Press Release, 24 April 2024
Adhoc Press Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOs sales
Press Release, 13 March 2024
Adhoc Press Release
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Press Release, 27 December 2023
Adhoc Press Release
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
Press Release, 12 October 2023
Adhoc Press Release
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
adhoc-press-releases